Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for producing recombinant human-like collagen by expression by Pichia pastoris

A technology of human-like collagen and Pichia pastoris, applied in the field of protein engineering, can solve the problems of easy formation of inclusion bodies, easy rejection, low purity, etc., and achieves easy genetic engineering operation, high density fermentation, and high protein yield. Effect

Inactive Publication Date: 2011-08-10
陕西九州生物医药科技集团有限公司
View PDF2 Cites 27 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the demand for collagen in the market is increasing, and its main source is extracted from animal bodies by acid-base method. However, although the yield of this collagen is high, it has poor water solubility and low purity. It is prone to rejection and has the disadvantages of virus hidden dangers, which inhibits the application of collagen in various industries.
With the development of biotechnology, people have also achieved success in expressing collagen by using transgenic and gene recombination technologies, such as using mammalian cells, insect cell expression systems and E. coli expression systems, etc. Although mammalian cells and insect cell expression systems can express Eukaryotic cell protein components with complex structure, but complex operation, low expression level, high cost of large-scale production, and difficult to be widely used. Although the Escherichia coli expression system has a high expression level, it is easy to form inclusion bodies, resulting in relatively low Problems such as multi-heteroproteins, which lead to difficulties in later purification and low recovery

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for producing recombinant human-like collagen by expression by Pichia pastoris
  • Method for producing recombinant human-like collagen by expression by Pichia pastoris
  • Method for producing recombinant human-like collagen by expression by Pichia pastoris

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0016] The production method for expressing recombinant humanoid collagen in Pichia pastoris includes: primary seed cultivation, secondary seed cultivation, fermenter cultivation and induced expression, centrifuging the fermented liquid after induced expression, and collecting the centrifuged supernatant in sequence. Concentration, gel column chromatography, precipitation decolorization, ion exchange chromatography and ultrafiltration desalting to obtain recombinant human-like collagen.

[0017] 1. Strain: Pichia pastoris C13, preservation number: CGMCCNo.4437, preservation date: December 8, 2010;

[0018] 2. Culture medium:

[0019] (1) The seed medium is BMGY medium, which consists of:

[0020] Yeast Extract Powder 10g / L Tryptone 20g / L

[0021] pH6.0 potassium phosphate buffer solution 100mmol / L YNB 13.4g / L

[0022] Biotin 0.2mg / L Glycerin 10mL / L.

[0023] (2) The fermentation medium consists of:

[0024] Glycerin 40g / L K 2 SO 4 18.2g / L

[0025] h 3 PO 4 ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a method for producing recombinant human-like collagen by expression by Pichia pastoris, which adopts Pichia pastoris C13 with a collection number CGMCC No.4437 as a strain and comprises: culturing primary seeds, culturing secondary seeds, culturing in a fermentation tank and inducing expression; and centrifuging fermentation liquor obtained after induced expression, collecting supernate after centrifugation, and performing concentration, gel column chromatography, precipitate decolorization, ion-exchange column chromatography and ultrafiltration for desalination in turn to obtain the recombinant human-like collagen. Compared with other purification methods, the method is simpler in process and higher in target protein yield, realizes a recovery rate of over 60 percent and a purity of over 95 percent, can realize complete decolorization and is suitable for industrial large-scale production of the recombinant human-like collagen.

Description

technical field [0001] The invention belongs to the technical field of protein engineering, and in particular relates to a production method for expressing recombinant human-like collagen in Pichia pastoris. Background technique [0002] Collagen is the most abundant protein in the body, accounting for about 25% to 33% of human protein. It is widely distributed in various tissues and organs of the body, such as skin, bones, cartilage, cornea, blood vessels, etc., especially in the skin and connective tissue of the human body. Tissues contain a lot of collagen. As a kind of adhesive substance of connective tissue, collagen plays an important role in maintaining the normal physiological functions of cells, tissues and organs. [0003] As a natural biological resource, collagen has been widely used in biomedicine, cosmetics, food and other industries. At present, the demand for collagen in the market is increasing, and its main source is extracted from animal bodies by acid-b...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12P21/02C07K1/36
Inventor 侯增淼张凤龙聂苏秦
Owner 陕西九州生物医药科技集团有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products